Chordate Medical Holding Stock Price To Earnings To Growth
CMH Stock | 12.55 0.25 1.95% |
Chordate Medical Holding fundamentals help investors to digest information that contributes to Chordate Medical's financial success or failures. It also enables traders to predict the movement of Chordate Stock. The fundamental analysis module provides a way to measure Chordate Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Chordate Medical stock.
Chordate |
Chordate Medical Holding Company Price To Earnings To Growth Analysis
Chordate Medical's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
Competition |
Based on the latest financial disclosure, Chordate Medical Holding has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Medical Devices industry. The price to earnings to growth for all Sweden stocks is 100.0% higher than that of the company.
Did you try this?
Run Portfolio Anywhere Now
Portfolio AnywhereTrack or share privately all of your investments from the convenience of any device |
All Next | Launch Module |
Chordate Fundamentals
Return On Equity | -1.68 | |||
Return On Asset | -0.71 | |||
Operating Margin | (54.40) % | |||
Current Valuation | 102.78 M | |||
Shares Outstanding | 157.71 M | |||
Shares Owned By Insiders | 39.97 % | |||
Price To Book | 5.80 X | |||
Price To Sales | 3,320 X | |||
Revenue | 618.01 K | |||
Gross Profit | 1.93 M | |||
EBITDA | (16.85 M) | |||
Net Income | (19.76 M) | |||
Book Value Per Share | 0.12 X | |||
Cash Flow From Operations | (17.43 M) | |||
Earnings Per Share | (0.18) X | |||
Beta | 1.27 | |||
Market Capitalization | 80.99 M | |||
Total Asset | 31.22 M | |||
Net Asset | 31.22 M |
About Chordate Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Chordate Medical Holding's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chordate Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chordate Medical Holding based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Chordate Stock Analysis
When running Chordate Medical's price analysis, check to measure Chordate Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chordate Medical is operating at the current time. Most of Chordate Medical's value examination focuses on studying past and present price action to predict the probability of Chordate Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chordate Medical's price. Additionally, you may evaluate how the addition of Chordate Medical to your portfolios can decrease your overall portfolio volatility.